Skip to main content
Signal8

Carruthers R Michael

SEC insider (Form 3/4/5 filer). CIK 0001644467. Director at OnKure Therapeutics, Inc. (OKUR) and 2 other issuers. 24 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in BOULDER, CO.

Companies Carruthers R Michael has filed insider reports for

  • OnKure Therapeutics, Inc. (OKUR): Director
  • Edgewise Therapeutics, Inc. (EWTX): Officer, Chief Financial Officer
  • Elevation Oncology, Inc. (ELEV): Director
Carruthers R Michael profile photo

Carruthers R Michael

CIK: 0001644467

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (25.0%)

Position reduction

Option Exercises (M)5 (20.8%)

Derivative conversions

Awards (A)8 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)5 (20.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

OnKure Therapeutics, Inc. logo
OKUR

OnKure Therapeutics, Inc.

Director
Edgewise Therapeutics, Inc. logo
EWTX

Edgewise Therapeutics, Inc.

Officer
Elevation Oncology, Inc. logo
ELEV

Elevation Oncology, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (24 total)

  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Award

    Stock Option (right to buy)

    Direct
    22.4K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Jun 4, 2026
    Award

    Stock Option (right to buy)

    Direct
    7.7K shares-
  • Edgewise Therapeutics, Inc. logo
    EWTX

    Edgewise Therapeutics, Inc.

    Aug 12, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    161.3K shares-
  • Edgewise Therapeutics, Inc. logo
    EWTX

    Edgewise Therapeutics, Inc.

    Aug 12, 2025
    Sale
    Direct
    1.4K shares at avg. $13.39$19K
  • Edgewise Therapeutics, Inc. logo
    EWTX

    Edgewise Therapeutics, Inc.

    Aug 12, 2025
    Exercise
    Direct
    5.8K shares-
  • Edgewise Therapeutics, Inc. logo
    EWTX

    Edgewise Therapeutics, Inc.

    Aug 12, 2025
    Award

    Restricted Stock Units

    Direct
    26.9K shares-
  • Elevation Oncology, Inc. logo
    ELEV

    Elevation Oncology, Inc.

    Jul 23, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    31.2K shares-
  • Elevation Oncology, Inc. logo
    ELEV

    Elevation Oncology, Inc.

    Jul 23, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    47.3K shares-
  • Elevation Oncology, Inc. logo
    ELEV

    Elevation Oncology, Inc.

    Jul 23, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    15.6K shares-
  • Elevation Oncology, Inc. logo
    ELEV

    Elevation Oncology, Inc.

    Jul 23, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    35K shares-

1-10 of 24